n-acetylaspartic acid has been researched along with Huntington Disease in 29 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 7 (24.14) | 18.2507 |
2000's | 13 (44.83) | 29.6817 |
2010's | 9 (31.03) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Casseb, RF; Castellano, G; Cendes, F; D'Abreu, A; Lopes-Cendes, I; Ruocco, HH | 1 |
Aylward, EH; Conley, KE; Laurino, MY; Padowski, JM; Richards, TL; Samii, A; Weaver, KE | 1 |
Adams, W; Beglinger, LJ; Fiedorowicz, J; Gasparovic, C; Jorge, R; Magnotta, VA; Paulsen, J; Yager, JR | 1 |
Dumas, EM; Kan, HE; Roos, RA; Teeuwisse, WM; van Buchem, MA; van den Bogaard, SJ; van der Grond, J; Webb, A | 1 |
Bechtel, N; Bohlen, S; Carter, K; Coleman, AJ; Creighton, S; Dar Santos, R; Decolongon, J; Hayden, MR; Johnson, HJ; Laule, C; Leavitt, BR; Mackay, AL; Milner, RA; Reilmann, R; Sturrock, A; Tabrizi, SJ; Wyper, K | 1 |
Morton, AJ; Sawiak, SJ; Wood, NI | 1 |
Joseph, SA; Mark, LP; Prost, RW; Reynolds, NC | 1 |
Bechtel, N; Coleman, AJ; Creighton, S; Dar Santos, R; Decolongon, J; Hayden, MR; Laule, C; Leavitt, BR; Mackay, AL; Reilmann, R; Sturrock, A; Tabrizi, SJ | 1 |
Ceci, E; de Tommaso, M; Franco, G; Livrea, P; Pica, C; Ruggieri, M; Sciruicchio, V; Serpino, C; Trojano, M | 1 |
Barker, PB; Bassett, SS; Brandt, J; Carass, A; Edden, RA; Liu, X; Margolis, RL; Oishi, K; Redgrave, GW; Ross, CA; Shanahan, M; Unschuld, PG; van Zijl, PC; Wang, X | 1 |
Blamire, AM; Manners, DN; Rajagopalan, B; Schapira, AH; Styles, P; Tabrizi, SJ; Warner, TT | 2 |
Cecil, KM; Doescher, J; Jones, BV; Kiefer, AM; Schapiro, M | 1 |
Mark, LP; Prost, RW; Reynolds, NC | 1 |
Auer, DP; Bender, A; Bender, J; Dose, M; Gasser, T; Klopstock, T; Merl, T; Reilmann, R; Saemann, P; Weindl, A; Yassouridis, A | 1 |
Hanstock, CC; Martin, WR; Wieler, M | 1 |
Cendes, F; Li, LM; Lopes-Cendes, I; Ruocco, HH | 1 |
Ross, BD | 1 |
Beal, MF; Jenkins, BG; Koroshetz, WJ; Rosen, BR | 1 |
Beal, MF; Brouillet, E; Chen, YC; Jenkins, BG; Kirschner, P; Rosen, BR; Schulz, JB; Storey, E | 1 |
Brooks, DJ; Bryant, DJ; Harding, AE; Marcus, CD; Sargentoni, J; Taylor-Robinson, SD; Weeks, RA | 1 |
Harms, L; Ludolph, AC; Meierkord, H; Pfeiffer, L; Timm, G | 1 |
Carter, RE; Coyle, JT; Passani, LA; Vonsattel, JP | 1 |
Blüml, S; Dubowitz, D; Hoang, TQ; Jacques, DB; Kopyov, OV; Lin, A; Ross, BD; Seymour, K; Tan, J | 1 |
Andreassen, OA; Beal, MF; Ferrante, RJ; Jenkins, BG; Klivenyi, P; Kustermann, E; Rosen, BR | 1 |
Andreassen, OA; Beal, MF; Dedeoglu, A; Ferrante, RJ; Hersch, SM; Jenkins, BG; Kaddurah-Daouk, R; Kubilus, JK; Kuemmerle, S | 1 |
Blakemore, C; Cordery, P; Dixon, RM; Hannan, AJ; Styles, P; van Dellen, A; Welch, J; York, D | 1 |
Andreassen, OA; Beal, MF; Borchelt, DR; Browne, SE; Dedeoglu, A; Ferrante, KL; Ferrante, RJ; Friedlich, A; Hersch, SM; Jenkins, BG; Ross, CA; Schilling, G; Thomas, M | 1 |
Dunlop, DS; Lajtha, A; Mc Hale, DM | 1 |
3 trial(s) available for n-acetylaspartic acid and Huntington Disease
Article | Year |
---|---|
Creatine therapy for Huntington's disease: clinical and MRS findings in a 1-year pilot study.
Topics: Adenosine Triphosphate; Aspartic Acid; Brain; Choline; Creatine; Diarrhea; Dietary Supplements; Dose-Response Relationship, Drug; Humans; Huntington Disease; Magnetic Resonance Spectroscopy; Muscle, Skeletal; Nausea; Neuropsychological Tests; Phosphocreatine; Pilot Projects; Reference Values; Safety; Treatment Outcome | 2003 |
Creatine supplementation lowers brain glutamate levels in Huntington's disease.
Topics: Administration, Oral; Adult; Aspartic Acid; Brain; Cerebral Cortex; Creatine; Down-Regulation; Energy Metabolism; Female; Glutamic Acid; Glutamine; Humans; Huntington Disease; Magnetic Resonance Spectroscopy; Male; Middle Aged; Neurologic Examination; Neuroprotective Agents; Pilot Projects; Treatment Outcome | 2005 |
High-dose creatine therapy for Huntington disease: a 2-year clinical and MRS study.
Topics: Administration, Oral; Aspartic Acid; Body Weight; Brain; Creatine; Creatinine; Dose-Response Relationship, Drug; Energy Metabolism; Humans; Huntington Disease; Magnetic Resonance Spectroscopy; Neuropsychological Tests; Patient Compliance; Phosphocreatine; Pilot Projects; Treatment Outcome; Up-Regulation | 2005 |
26 other study(ies) available for n-acetylaspartic acid and Huntington Disease
Article | Year |
---|---|
Thalamic metabolic abnormalities in patients with Huntington's disease measured by magnetic resonance spectroscopy.
Topics: Adolescent; Adult; Aged; Aspartic Acid; Case-Control Studies; Creatine; Deuterium; Dipeptides; Female; Glycerylphosphorylcholine; Humans; Huntington Disease; Magnetic Resonance Spectroscopy; Male; Middle Aged; Motor Activity; Phosphocreatine; Phosphorylcholine; Thalamic Diseases; Thalamus; Trinucleotide Repeats; Young Adult | 2013 |
Neurochemical correlates of caudate atrophy in Huntington's disease.
Topics: Adult; Aged; Aspartic Acid; Atrophy; Caudate Nucleus; Female; Glutamic Acid; Humans; Huntington Disease; Magnetic Resonance Imaging; Male; Middle Aged; Motor Activity; Mutation; Young Adult | 2014 |
Preliminary study of the association of white-matter metabolite concentrations with disease severity in patients with Huntington's disease.
Topics: Aspartic Acid; Humans; Huntington Disease; Magnetic Resonance Spectroscopy; Nerve Fibers, Myelinated; Protons; Trinucleotide Repeats | 2014 |
Longitudinal metabolite changes in Huntington's disease during disease onset.
Topics: Adult; Aspartic Acid; Caudate Nucleus; Creatinine; Female; Follow-Up Studies; Humans; Huntington Disease; Longitudinal Studies; Magnetic Resonance Spectroscopy; Male; Middle Aged; Molecular Imaging; Prefrontal Cortex; Putamen | 2014 |
A longitudinal study of magnetic resonance spectroscopy Huntington's disease biomarkers.
Topics: Adult; Analysis of Variance; Aspartic Acid; Biomarkers; Brain; Cross-Sectional Studies; Female; Humans; Huntington Disease; Inositol; Longitudinal Studies; Magnetic Resonance Spectroscopy; Male; Middle Aged; Putamen; Statistics as Topic; Time Factors; White Matter | 2015 |
Similar Progression of Morphological and Metabolic Phenotype in R6/2 Mice with Different CAG Repeats Revealed by In Vivo Magnetic Resonance Imaging and Spectroscopy.
Topics: Animals; Aspartic Acid; Brain; Disease Models, Animal; Disease Progression; Glutamic Acid; Humans; Huntingtin Protein; Huntington Disease; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Mice; Mice, Transgenic; Trinucleotide Repeats | 2016 |
MR-spectroscopic findings in juvenile-onset Huntington's disease.
Topics: Adolescent; Aspartic Acid; Brain Mapping; Child; Child, Preschool; Creatine; Female; Glutamic Acid; Humans; Huntington Disease; Magnetic Resonance Spectroscopy; Male; Protons; Putamen; Trinucleotide Repeats; Young Adult | 2008 |
Magnetic resonance spectroscopy biomarkers in premanifest and early Huntington disease.
Topics: Adult; Aspartic Acid; Biomarkers; Cohort Studies; Early Diagnosis; Female; Humans; Huntington Disease; Longitudinal Studies; Magnetic Resonance Spectroscopy; Male; Middle Aged; Prospective Studies; Putamen | 2010 |
Serum levels of N-acetylaspartate in Huntington's disease: preliminary results.
Topics: Adolescent; Adult; Aged; Aspartic Acid; Case-Control Studies; Female; Humans; Huntington Disease; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Middle Aged | 2012 |
Brain metabolite alterations and cognitive dysfunction in early Huntington's disease.
Topics: Adult; Analysis of Variance; Aspartic Acid; Brain; Cognition Disorders; Female; Glutamic Acid; Humans; Huntington Disease; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Middle Aged; Neuropsychological Tests; Regression Analysis; Trinucleotide Repeat Expansion | 2012 |
MR imaging and spectroscopy in juvenile Huntington disease.
Topics: Aspartic Acid; Brain; Caudate Nucleus; Child; Creatinine; Genetic Testing; Humans; Huntington Disease; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Putamen | 2004 |
Heterogeneity in 1H-MRS profiles of presymptomatic and early manifest Huntington's disease.
Topics: Adult; Age of Onset; Aged; Aspartic Acid; Early Diagnosis; Female; Glutamic Acid; Glutamine; Humans; Huntington Disease; Magnetic Resonance Spectroscopy; Male; Middle Aged; Protons; Putamen | 2005 |
Is brain lactate increased in Huntington's disease?
Topics: Adult; Aspartic Acid; Brain; Case-Control Studies; Choline; Creatine; Female; Humans; Huntington Disease; Lactic Acid; Magnetic Resonance Spectroscopy; Male; Middle Aged | 2007 |
Evidence of thalamic dysfunction in Huntington disease by proton magnetic resonance spectroscopy.
Topics: Adult; Age of Onset; Aged; Analysis of Variance; Aspartic Acid; Creatine; Female; Humans; Huntington Disease; Magnetic Resonance Spectroscopy; Male; Middle Aged; Protons; Radionuclide Imaging; Thalamus | 2007 |
Re: Long-term fetal cell transplant in Huntington disease: stayin' alive.
Topics: Aspartic Acid; Cell Differentiation; Corpus Striatum; Fetal Tissue Transplantation; Graft Survival; Growth Cones; Humans; Huntington Disease; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Monitoring, Physiologic; Neural Pathways; Stem Cell Transplantation | 2008 |
Evidence for impairment of energy metabolism in vivo in Huntington's disease using localized 1H NMR spectroscopy.
Topics: Adult; Aspartic Acid; Basal Ganglia; Choline; Creatine; Energy Metabolism; Female; Humans; Huntington Disease; Lactates; Lactic Acid; Magnetic Resonance Spectroscopy; Male; Middle Aged; Occipital Lobe; Protons; Reference Values | 1993 |
Non-invasive neurochemical analysis of focal excitotoxic lesions in models of neurodegenerative illness using spectroscopic imaging.
Topics: Aging; Animals; Aspartic Acid; Electron Transport Complex II; Energy Metabolism; Huntington Disease; Lactates; Lactic Acid; Magnetic Resonance Spectroscopy; Male; Multienzyme Complexes; Nerve Degeneration; Neurochemistry; Neurotoxins; Oxidoreductases; Parkinson Disease, Secondary; Rats; Rats, Sprague-Dawley; Succinate Dehydrogenase | 1996 |
Proton magnetic resonance spectroscopy in Huntington's disease: evidence in favour of the glutamate excitotoxic theory.
Topics: Aspartic Acid; Cerebral Cortex; Corpus Striatum; Genetic Carrier Screening; Glutamic Acid; Glutamine; Humans; Huntington Disease; Magnetic Resonance Imaging; Nerve Degeneration; Reference Values; Synaptic Transmission | 1996 |
Decreased N-acetyl-aspartate/choline ratio and increased lactate in the frontal lobe of patients with Huntington's disease: a proton magnetic resonance spectroscopy study.
Topics: Adult; Aged; Aspartic Acid; Choline; Female; Frontal Lobe; Humans; Huntington Disease; Lactic Acid; Magnetic Resonance Spectroscopy; Male; Middle Aged | 1997 |
N-acetylaspartylglutamate, N-acetylaspartate, and N-acetylated alpha-linked acidic dipeptidase in human brain and their alterations in Huntington and Alzheimer's diseases.
Topics: Alzheimer Disease; Amino Acids; Antigens, Surface; Aspartic Acid; Brain; Case-Control Studies; Cell Count; Dipeptidases; Dipeptides; Glutamate Carboxypeptidase II; Humans; Huntington Disease; Neurons; Neuropeptides; Reference Values | 1997 |
In vivo magnetic resonance spectroscopy of human fetal neural transplants.
Topics: Adult; Aspartic Acid; Brain; Fetal Tissue Transplantation; Humans; Huntington Disease; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Parkinson Disease | 1999 |
Nonlinear decrease over time in N-acetyl aspartate levels in the absence of neuronal loss and increases in glutamine and glucose in transgenic Huntington's disease mice.
Topics: Animals; Aspartic Acid; Blood Glucose; Brain; Glucose; Glutamine; Humans; Huntington Disease; Magnetic Resonance Spectroscopy; Mice; Mice, Transgenic; Neurons; Nonlinear Dynamics; Time Factors | 2000 |
Neuroprotective effects of creatine in a transgenic mouse model of Huntington's disease.
Topics: Animals; Animals, Genetically Modified; Aspartic Acid; Atrophy; Brain; Corpus Striatum; Creatine; Crosses, Genetic; Dietary Supplements; Female; Humans; Huntingtin Protein; Huntington Disease; Magnetic Resonance Imaging; Male; Mice; Mice, Inbred Strains; Motor Activity; Nerve Tissue Proteins; Neurons; Neuroprotective Agents; Nuclear Proteins | 2000 |
N-Acetylaspartate and DARPP-32 levels decrease in the corpus striatum of Huntington's disease mice.
Topics: Animals; Aspartic Acid; Biomarkers; Calbindins; Choline; Corpus Striatum; Creatine; Dopamine and cAMP-Regulated Phosphoprotein 32; Huntington Disease; Immunohistochemistry; Magnetic Resonance Imaging; Male; Mice; Mice, Transgenic; Nerve Tissue Proteins; Neurons; Phosphoproteins; S100 Calcium Binding Protein G | 2000 |
Creatine increase survival and delays motor symptoms in a transgenic animal model of Huntington's disease.
Topics: Animals; Aspartic Acid; Blood Glucose; Brain Chemistry; Cell Survival; Creatinine; Disease Models, Animal; Energy Metabolism; Female; Huntingtin Protein; Huntington Disease; Hyperglycemia; Insulin; Magnetic Resonance Spectroscopy; Male; Mice; Mice, Transgenic; Motor Activity; Neostriatum; Nerve Tissue Proteins; Neurons; Nuclear Proteins; Organ Size; Survival Rate | 2001 |
Decreased brain N-acetylaspartate in Huntington's disease.
Topics: Aspartic Acid; Brain; Female; Humans; Huntington Disease; Male | 1992 |